New drugs were approved for the oncology field, and for treating ophthalmic, gastrohepatic, hemologic, and metabolic disorders.

In a phase 3 trial, 25 mg of COMP360 psilocybin significantly improved MADRS scores in treatment-resistant depression compared with a 1 mg dose.

Higher prediagnostic intake of vitamin B6 and folate is associated with a reduced risk for all-cause mortality in patients with Parkinson disease.

Researchers found that intense exercise acts as a low-cost interoceptive exposure strategy, reducing panic attacks and depressive symptoms.

Medicare's 2023 policy shift did not lower SNF spending or utilization but kept patients in hospitals longer to meet coverage requirements.

Prenatal exposure to PPIs and H2 receptor antagonists were not found to increase risk for neuropsychiatric disorders in offspring.

The AMA and the Vaccine Integrity Project have announced plans to create an independent vaccine safety and efficacy review process.

HealthDay News — Lifetime exposure to cognitive enrichment is associated with a lower risk for Alzheimer disease (AD) dementia and a slower rate of cognitive decline, according to a study published ...

Lisa Du Breuil, LICSW, and Rachel Millner, PsyD, discuss the "honeymoon period" of bariatric surgery, noting that depression and other mental health concerns may emerge after surgery.

Medical experts disagree with recent assertions by the US Health Secretary that schizophrenia may be cured by adhering to a ketogenic diet.

The HHS plans to cut $600M in grants from several Democrat-led states, claiming a departure from agency priorities by states impacted.